WO2003064394A8 - Heterocycles pentagonaux utilises en tant qu'agents antiviraux - Google Patents
Heterocycles pentagonaux utilises en tant qu'agents antivirauxInfo
- Publication number
- WO2003064394A8 WO2003064394A8 PCT/EP2003/000376 EP0300376W WO03064394A8 WO 2003064394 A8 WO2003064394 A8 WO 2003064394A8 EP 0300376 W EP0300376 W EP 0300376W WO 03064394 A8 WO03064394 A8 WO 03064394A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antiviral agents
- ring heterocycles
- heterocycles used
- production
- medicines used
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003564017A JP2005521669A (ja) | 2002-01-28 | 2003-01-16 | 抗ウイルス剤として使用するための5員ヘテロ環 |
EP03734671A EP1472229A1 (fr) | 2002-01-28 | 2003-01-16 | Heterocycles pentagonaux utilises en tant qu'agents antiviraux |
CA002474456A CA2474456A1 (fr) | 2002-01-28 | 2003-01-16 | Heterocycles pentagonaux utilises en tant qu'agents antiviraux |
AU2003239243A AU2003239243A1 (en) | 2002-01-28 | 2003-01-16 | 5-ring heterocycles used as antiviral agents |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10203086.3 | 2002-01-28 | ||
DE10203086A DE10203086A1 (de) | 2002-01-28 | 2002-01-28 | 5-Ring Heterozyklen |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003064394A1 WO2003064394A1 (fr) | 2003-08-07 |
WO2003064394A8 true WO2003064394A8 (fr) | 2003-12-24 |
Family
ID=7713161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/000376 WO2003064394A1 (fr) | 2002-01-28 | 2003-01-16 | Heterocycles pentagonaux utilises en tant qu'agents antiviraux |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1472229A1 (fr) |
JP (1) | JP2005521669A (fr) |
AU (1) | AU2003239243A1 (fr) |
CA (1) | CA2474456A1 (fr) |
DE (1) | DE10203086A1 (fr) |
WO (1) | WO2003064394A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1797037T1 (sl) * | 2004-09-29 | 2015-06-30 | Bayer Healthcare Llc | Postopek priprave 4-(4-((((4-kloro-3-(trifluorometil)fenil)amino)karbonil)amino) fenioksi)N-metilpiridin-2-karboksamida |
WO2014130582A2 (fr) | 2013-02-19 | 2014-08-28 | Senomyx, Inc. | Composés utiles comme modulateurs de trpm8 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES8101067A1 (es) * | 1978-08-25 | 1980-12-01 | Thomae Gmbh Dr K | Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona |
KR19990072123A (ko) * | 1995-12-14 | 1999-09-27 | 폴락 돈나 엘. | 고나도트로핀분비호르몬의길항제및이를포함하는약제학적조성물 |
EP1043995B9 (fr) * | 1997-12-22 | 2008-10-08 | Bayer Pharmaceuticals Corp. | INHIBITION DE L'ACTIVITE DE p38 KINASE AU MOYEN D'UREES HETEROCYCLIQUES ARYLE ET HETEROARYLE SUBSTITUEES |
-
2002
- 2002-01-28 DE DE10203086A patent/DE10203086A1/de not_active Withdrawn
-
2003
- 2003-01-16 EP EP03734671A patent/EP1472229A1/fr not_active Withdrawn
- 2003-01-16 WO PCT/EP2003/000376 patent/WO2003064394A1/fr active Application Filing
- 2003-01-16 AU AU2003239243A patent/AU2003239243A1/en not_active Abandoned
- 2003-01-16 CA CA002474456A patent/CA2474456A1/fr not_active Abandoned
- 2003-01-16 JP JP2003564017A patent/JP2005521669A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2474456A1 (fr) | 2003-08-07 |
WO2003064394A1 (fr) | 2003-08-07 |
DE10203086A1 (de) | 2003-07-31 |
AU2003239243A1 (en) | 2003-09-02 |
EP1472229A1 (fr) | 2004-11-03 |
JP2005521669A (ja) | 2005-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL300933I2 (nl) | Letermovir | |
WO2005063734A3 (fr) | Thiophenes substitues | |
EG25011A (en) | Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments. | |
WO2003080582A3 (fr) | Derives de fredericamycine | |
WO2004006858A3 (fr) | Composes, compositions et methodes d'utilisation de ces derniers | |
AU2003285091A1 (en) | Interferon antagonists useful for the treatment of interferon related diseases | |
WO2005039504A3 (fr) | Composes et methodes permettant de traiter les maladies et etats pathologiques lies au recepteur 2 de type toll | |
NO20035025L (no) | Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet. | |
WO2004071382A3 (fr) | Heterocycles substitues | |
ZA200501288B (en) | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma. | |
HK1093729A1 (en) | Substituted quinolones | |
WO2006089664A3 (fr) | Imidazoles substitues par heterocyclylamide | |
CA2474510A1 (fr) | Heterocycles tricycliques fusionnes utilises dans le traitement de troubles hyperproliferatifs | |
AU2003258145A8 (en) | Substituted phenylindoles for the treatment of hiv | |
IL163951A (en) | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them | |
WO2003033557A3 (fr) | Copolymeres fluores, leur production et leur utilisation | |
NO20033318D0 (no) | 2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav | |
AU2002319296A1 (en) | Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with CGMP regulated processes | |
AU2003303217A1 (en) | Use of substituted 2,5-diamidoindoles for the treatment of urological diseases | |
AU2003289652A1 (en) | The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion | |
WO2005047278A3 (fr) | Dihydroquinazolines ii substituees | |
WO2003064394A8 (fr) | Heterocycles pentagonaux utilises en tant qu'agents antiviraux | |
EP1469844A4 (fr) | Procede et compose pour la prophylaxie ou le traitement d'une condition d'immunodeficience, telle que le sida | |
WO2003024996A3 (fr) | Macrocycles antibacteriens | |
AU2002365288A1 (en) | Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: IN PCT GAZETTE 32/2003 ADD "DECLARATION UNDER RULE 4.17: - AS TO APPLICANT?S ENTITLEMENT TO APPLY FOR AND BE GRANTED A PATENT (RULE 4.17(II))." |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003734671 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2474456 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003564017 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003734671 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |